Dominican Republic vs Netherlands: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage
Dominican Republic
87.0%
in 2024
Netherlands
88.0%
in 2024
Dominican Republic rank
78th
Netherlands rank
75th
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage over time
- Dominican Republic
- Netherlands
How they compare
Netherlands currently reports 88.0% against 87.0% in Dominican Republic, a difference of 1.0%.
Across all 11 years both countries report, Netherlands has been ahead every year.
Dominican Republic ranks 78th and Netherlands ranks 75th of 146 countries.
Netherlands has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Dominican Republic | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 46.0% | 93.7% | 47.7% | Netherlands |
| 2020s | 78.2% | 90.4% | 12.2% | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage, Dominican Republic or Netherlands?
- Netherlands, at 88.0% against 87.0% in Dominican Republic as of 2024.
- What is the difference in pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage between Dominican Republic and Netherlands?
- 1.0%, with Netherlands ahead.
- How many years of comparable data are there for Dominican Republic and Netherlands?
- 11 years are reported by both, from 2014 to 2024.
- How do Dominican Republic and Netherlands rank globally for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Dominican Republic ranks 78th and Netherlands ranks 75th of 146 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.